大北農(002385.SZ)擬申請7.5億元的農業科技固定資產貸款 用於生物農業創新園項目
格隆匯12月27日丨大北農(002385.SZ)公佈,公司以志創世界級農業科技企業為目標,圍繞現代農業關鍵核心技術建成大型開放創新創業生態系統,爭取成為全球領先的現代農業技術創新中心、中國現代農業高技術原始創新策源地,公司擬建設大北農生物農業創新園,擬向中國農業發展銀行北京市密雲區支行(“農發行”)申請農業科技固定資產貸款,用於大北農生物農業創新園項目建設,申請貸款金額為人民幣7.5億元,貸款期限暫定為2019年12月31日至2028年12月30日,貸款利率等條款以雙方簽訂的借款合同為準。公司擬以自有資產為上述銀行貸款提供抵押。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.